ZYTIGA, also known by its generic name abiraterone acetate, is a medication primarily used in the treatment of prostate cancer. It belongs to a class of drugs known as androgen biosynthesis inhibitors, which work by reducing the production of androgens (male hormones) in the body. Since prostate cancer cells often rely on androgens to grow and spread, reducing their levels can help in controlling the progression of the disease. ZYTIGA is typically prescribed for men with advanced prostate cancer and is used in combination with prednisone, a corticosteroid that helps mitigate some of the side effects of abiraterone. This medication is taken orally and has become a key component in the management of metastatic castration-resistant prostate cancer, offering a treatment option that can extend survival and improve the quality of life for many patients facing this challenging condition.
When using ZYTIGA, a medication commonly prescribed for prostate cancer, it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label that accompanies the medicine. This ensures you're aware of the correct dosage and any potential interactions with other medications you might be taking. Inform your doctor about all other medicines you're currently on to avoid adverse interactions. Side effects of ZYTIGA can range from common issues such as fatigue, joint pain, and high blood pressure, to more rare but serious conditions like liver problems or heart failure. Given these possible side effects, it's important to monitor your health closely and report any unusual symptoms to your doctor immediately. Additionally, ZYTIGA may cause dizziness or fatigue in some individuals, so it's advisable to understand how this medication affects you before engaging in activities that require alertness, such as driving. Always prioritize safety and ensure you're following the prescribed treatment plan closely for the best possible outcome.